Pharmacological Investigation of <i>Asphodelus tenuifolius</i> Cav<i>.</i> for its Potential Against Thrombosis in Experimental Models.

Dose Response · 2022 · PMC9483973 · PMID 36132706

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In-vitro Clot Lysis/Thrombolysis Assay Figure 3 presents the thrombolytic activity of At.Cr with highly significant and dose reliant (1, 3, 5 and 10 mg/ml) increase in lysis of human blood clot.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.